ENGAGE AF TIMI

Related by string. * Engages . engages . engage . Engage : Neuberger Berman engages . Maclean enlightens engages . Glide Engage . Silverpop Engage B2B . Engage PR . Engage Mutual / afer . Afer . AFD . AFED . AFER . aF : af fairs . Af fairs . af * ing . af ter . Af rica . af * cking / TIMING IS . timid . Timid . Timis . Timi : Myocardial Infarction TIMI . Filippo Timi . MERLIN TIMI . TRITON TIMI . CLARITY TIMI . Timi Gustafson RD * *

Related by context. Frequent words. (Click for all words.) 64 Thrombolysis 63 Phase Ib clinical 63 Randomized controlled 63 double blinded placebo 63 Apixaban 63 placebo controlled Phase 62 phase IIb clinical 61 SWOG 61 subanalysis 60 AZOR 60 Phase III randomized 60 TRITON TIMI 60 Pivotal Trial 60 placebo controlled clinical 60 phase IIb 60 BAY #-# 60 Pivotal Phase 60 Multicenter 60 ganetespib 60 Traficet EN 60 StemEx 59 multicenter clinical 59 EndoTAG TM -1 59 PRECiSE 59 phase IIa 59 prospectively defined 59 prospective observational 59 prospective multicenter 59 placebo controlled randomized 59 nonrandomized 59 Pivotal Phase III 58 IMC A# 58 neoadjuvant 58 Natalizumab 58 pharmacokinetics PK 58 tesmilifene 58 dose cohorts 58 Phase 2a trial 58 Pharmacokinetic 58 randomized Phase III 58 lipid lowering therapy 58 Phase 1b trial 58 secondary efficacy endpoints 58 HSCT 58 irbesartan 57 Cethromycin 57 Anticoagulation 57 placebo controlled clinical trials 57 Phase Ib 57 Phase III Clinical Trial 57 prospective randomized controlled 57 placebo controlled studies 57 RRMS patients 57 subgroup analyzes 57 rNAPc2 57 placebo controlled trials 57 pharmacokinetic PK 57 pertuzumab 57 Gabapentin GR 57 nab paclitaxel 57 axitinib 57 RTOG 57 Phase IIb trials 57 dabigatran etexilate 57 Phase 1a 57 analgesic efficacy 57 atherothrombosis 57 Antihypertensive 56 Ischemic 56 glatiramer acetate 56 SYNTAX 56 relapsing multiple sclerosis 56 multicentre 56 Acute Myocardial Infarction 56 dose regimens 56 antihypertensive therapy 56 pharmacodynamic effects 56 Allovectin 7 R 56 ALLHAT 56 Phase 2b clinical 56 pramlintide 56 elotuzumab 56 ADHF 56 ximelagatran 56 metastatic hormone refractory 56 multicenter randomized 56 eplerenone 56 liver transplant recipients 56 ACZ# 56 6R BH4 56 NSABP 56 lipid lowering drugs 56 Phase III 56 Panzem R 56 substudy 56 Percutaneous Coronary Intervention 56 Dasatinib 56 GSK# [001] 56 Pulmonary Arterial Hypertension 56 oral anticoagulant 56 CCX#

Back to home page